View Author
dai: 15334671X
scopus: 7004480594

Hagen, T.L.M. ten

(Timo ten Hagen)

Supervisor (promotor) of 1 dissertation


tumor cancer patient treatment study effect macrophage perfusion expression melphalan liposomes melanoma response factor result activity ifn-y tissue tumor necrosis factor level limb perfusion necrosis infection survival protein immunomodulator t cells agent group liposomal model vessel pneumoniae cytokine il -2 blood liver therapy release breast mtppe concentration production le-mtppe administration tumor cells spleen hagen activation il -15 control interferon wild-type number eggermont increase oncol trial migration muramyl pancreatic t-cell assay 37 ° c murine temperature antibody mouse mutation sarcoma figure fraction tnf-a combination tumour septicemia il -21 ratio doxorubicin immunomodulation




10 Most Recent Publications

Angiogenesis: A prognostic determinant in pancreatic cancer? (Article)
Zee, J. van der Eijck, C.H.J. van Hop, W.C.J. Dekken, H. van Dicheva, B.M. Seynhaeve, A.L.B. Koning, G.A. Eggermont, A.M.M. Hagen, T.L.M. ten
2011-11-01
Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18 952) and prognostic value on treatment outcome (Article)
Bouwhuis, M.G. Collette, S. Suciu, S. Groot, E.R. de Kruit, W.H.J. Hagen, T.L.M. ten Aarden, L.A. Eggermont, A.M.M. Swaak, A.J.G.
2011-08-01
Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition (Article)
Krawczyk, P.M. Eppink, B. Soullié, T. Rens, J.A.P. Verhagen, H.J.M. O'Connor, M.J. Frankene, N.A.P. Hagen, T.L.M. ten Kanaar, R. Aten, J.A. Essers, J. Stap, J. Rodermond, H. Odijk, H. Zelensky, A. Bree, C. van Stalpers, L.J. Buist, M.R.
2011-06-14
Immunologic functions as prognostic indicators in melanoma (Article)
Bouwhuis, M.G. Hagen, T.L.M. ten Eggermont, A.M.M.
2011-04-01
Autoimmunity and treatment outcome in melanoma (Article)
Bouwhuis, M.G. Hagen, T.L.M. ten Suciu, S. Eggermont, A.M.M.
2011-03-01
Crossing barriers: The new dimension of 2D cell migration assays (Article)
Horssen, R. van Hagen, T.L.M. ten
2011-01-01
Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer (Article)
Zee, J. van der Hagen, T.L.M. ten Hop, W.C.J. Dekken, H. van Dicheva, B.M. Seynhaeve, A.L.B. Koning, G.A. Eggermont, A.M.M. Eijck, C.H.J. van
2010-12-01
Thermosensitive liposomes for the delivery of cancer therapeutics (Article)
Koning, G.A. Li, L. Hagen, T.L.M. ten
2010-11-01
Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors (Article)
Koning, G.A. Eggermont, A.M.M. Lindner, L.H. Hagen, T.L.M. ten
2010-08-01
Combination of IL-21 and IL-15 enhances tumour-specific cytotoxicity and cytokine production of TCR-transduced primary T cells (Article)
Pouw, N.M.C. Treffers-Westerlaken, E. Kraan, J. Wittink, F. Hagen, T.L.M. ten Verweij, J. Debets, J.E.M.A.
2010-06-01